{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:10:03Z","timestamp":1756282203953,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,12,23]]},"abstract":"<jats:p>A 72-year-old man with ulcerative colitis (UC) presented with complete left abducens nerve palsy. Although MRI showed no significant changes, cerebrospinal fluid analysis revealed pleocytosis and elevated protein and interleukin (IL)-6 levels. His serum proteinase 3-antineutrophil cytoplasmic antibody (PR3-ANCA) level was also elevated to 31.1\u2005U\/mL, but granulomatosis with polyangiitis was not observed. On the basis of the diagnosis of autoimmune cranial neuropathy, he was treated with steroid therapy. While tapering steroid therapy, his serum PR3-ANCA levels; cerebrospinal fluid findings, including IL-6 levels; and symptoms improved. Serum PR3-ANCA could be a useful parameter of neurological disorders associated with ANCA-positive UC.<\/jats:p>","DOI":"10.1136\/bcr-2016-218353","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T10:40:20Z","timestamp":1483958420000},"page":"bcr2016218353","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Proteinase 3-antineutrophil cytoplasmic antibody-positive ulcerative colitis presenting with abducens neuropathy"],"prefix":"10.1136","volume":"2017","author":[{"given":"Yuki","family":"Kirito","sequence":"first","affiliation":[{"name":"Department of Neurology, Seirei Hamamatu General Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seirei Hamamatu General Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seirei Hamamatu General Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.06.005"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8349-4"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6616(02)00026-8"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.4","first-page":"8764","article-title":"Neurological disorders and inflammatory bowel diseases","volume":"20","author":"Casella","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073454"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw003"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/0004-282X20140223","article-title":"A case-control study of the prevalence of neurological diseases in inflammatory bowel disease (IBD)","volume":"73","author":"Gondim Fde","year":"2015","journal-title":"Arq Neuropsiquiatr."},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2273.2000.00342.x","article-title":"Sensorineural hearing loss in ulcerative colitis","volume":"25","author":"Kumar","year":"2000","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.9","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2169\/internalmedicine.51.8616","article-title":"Ulcerative colitis associated with isolated unilateral hypoglossal nerve palsy","volume":"51","author":"Kawashima","year":"2012","journal-title":"Intern Med"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.10","doi-asserted-by":"crossref","unstructured":"Colombel JF , Sands BE , Rutgeerts P , et al . The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut 2016. doi:10.1136\/gutjnl-2015-311079 doi:10.1136\/gutjnl-2015-311079","DOI":"10.1136\/gutjnl-2015-311079"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01718.x"},{"key":"2025082700512394000_2017.jan09_1.bcr2016218353.12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.3.416"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-218353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:51:37Z","timestamp":1756281097000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-218353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":12,"alternative-id":["10.1136\/bcr-2016-218353"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-218353","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}